Intermountain Ventures

Tracked participation in 1 Atlas company, with 0 explicitly attributed leads.

1portfolio companies

1round participations

0lead positions

Sep 2020latest activity

Capital activity

Portfolio

CompanyLatest valuationFirst → latestRoundsRoleAttributed partner

RRecursionScienceRecursion is a clinical-stage TechBio company building an industrialized, AI-native drug discovery and development…$938.3MraisedRecent roundsPublic offering (underwritten) · Jun 2024$200M · Public shareholders (offering investors)Strategic investment (private investment in public equity / PIPE) · Jul 2023$50M · led by NVIDIAInitial Public Offering (IPO) / Public offering (pricing) · Apr 2021$436.4M · Baillie Gifford & Co. (clients incl. Scottish Mortgage Investment Trust plc), Mubadala Investment Company (entities affiliated) +1Recursion—Sep 2020 → Sep 20201 roundParticipant—

DateCompanyRoundRaisedValuationRoleEvidence

Sep 09, 2020RRecursionScienceRecursion is a clinical-stage TechBio company building an industrialized, AI-native drug discovery and development…$938.3MraisedRecent roundsPublic offering (underwritten) · Jun 2024$200M · Public shareholders (offering investors)Strategic investment (private investment in public equity / PIPE) · Jul 2023$50M · led by NVIDIAInitial Public Offering (IPO) / Public offering (pricing) · Apr 2021$436.4M · Baillie Gifford & Co. (clients incl. Scottish Mortgage Investment Trust plc), Mubadala Investment Company (entities affiliated) +1RecursionSeries D$239M—Participant

Source ↗+1 ↗

DateCompanyRoundRaisedValuationRoleEvidence

Source ↗+1 ↗